-
-
-
-
-
-
-
Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Moderna (MRNA) Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant
-
-
-
-
-
-
-
Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
U.S. FDA advisers recommend change to COVID vaccine composition for fall
-
-
-
-
-
-
-
U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna’s COVID-19 Vaccine
-
-
-
-
-
-
-
Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
-
-
-
-
-
-
-
J&J to seek U.S. FDA authorization of booster shot this week - NYT
-
15,627 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

